Skip to main content
Tech.euFundingExplorerBeta

CTI Life Sciences

Investor profile

Venture capital

CTI Life Sciences has backed 3 European tech companies across 3 funding rounds between 2022 and 2023, joining rounds totalling €181M. Most active in Healthtech. Data as of Nov 2026.

Deals
3
distinct rounds
Companies
3
backed
Active span
2022–2023
2 yrs
Total round €
€181M
sum of rounds joined

Deals by year

distinct rounds / year
CTI Life Sciences — deals by year — interactive chart.
Data table
CTI Life Sciences — deals by year
20222
20231

Top sectors

by deals
CTI Life Sciences — top sectors — interactive chart.
Data table
CTI Life Sciences — top sectors
Healthtech3

Stages

by deals
CTI Life Sciences — stages — interactive chart.
Data table
CTI Life Sciences — stages
Seed1
Series A1
Series C1

Countries

by deals
CTI Life Sciences — countries — interactive chart.
Data table
CTI Life Sciences — countries
France2
UK1

Co-investment network

shared rounds
Co-investment network — interactive chart.
CTI Life Sciences — 3 dealsCTI Life Sciences3B Future Health Fund — 1 shared deals · click to open3B Future Health FundadMare BioInnovations — 1 shared deals · click to openadMare BioInnovationsAdvent Life Sciences — 1 shared deals · click to openAdvent Life SciencesAndera Partners — 1 shared deals · click to openAndera PartnersATEM — 1 shared deals · click to openATEMCambridge Innovation Capital — 1 shared deals · click to openCambridge Innovation CapitalCrédit Agricole Création — 1 shared deals · click to openCrédit Agricole CréationEQT Life Sciences — 1 shared deals · click to openEQT Life SciencesFonds de solidarité FTQ — 1 shared deals · click to openFonds de solidarité FTQHarrington Discovery Institute — 1 shared deals · click to openHarrington Discovery InstituteInnobio 2 — 1 shared deals · click to openInnobio 2Intermediate Capital Group — 1 shared deals · click to openIntermediate Capital GroupKurma Partners — 1 shared deals · click to openKurma PartnersMass General Brigham Ventures — 1 shared deals · click to openMass General Brigham VenturesNovateur Ventures — 1 shared deals · click to openNovateur VenturesNovo Holdings — 1 shared deals · click to openNovo HoldingsOmnes Capital — 1 shared deals · click to openOmnes CapitalOrbiMed — 1 shared deals · click to openOrbiMed

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Amolyt PharmaFrance1€129M
Domain TherapeuticsFrance1€40M
EpitopeaUK1€12M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Amolyt PharmaSeries C€129M2023-01
Domain TherapeuticsSeries A€40M2022-05
EpitopeaSeed€12M2022-04
← Back to investors